Compare LEGN & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEGN | CHH |
|---|---|---|
| Founded | 2014 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.7B |
| IPO Year | 2020 | 1997 |
| Metric | LEGN | CHH |
|---|---|---|
| Price | $17.42 | $118.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 18 |
| Target Price | $42.46 | ★ $117.18 |
| AVG Volume (30 Days) | ★ 2.3M | 549.4K |
| Earning Date | 11-10-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | N/A | ★ 27.42 |
| EPS | N/A | ★ 3.12 |
| Revenue | N/A | ★ $1,596,793,000.00 |
| Revenue This Year | $38.71 | $2.74 |
| Revenue Next Year | $18.83 | $3.68 |
| P/E Ratio | ★ N/A | $37.96 |
| Revenue Growth | N/A | ★ 0.75 |
| 52 Week Low | $16.24 | $84.04 |
| 52 Week High | $37.50 | $123.82 |
| Indicator | LEGN | CHH |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 63.55 |
| Support Level | $17.43 | $104.17 |
| Resistance Level | $19.92 | $122.88 |
| Average True Range (ATR) | 1.50 | 3.61 |
| MACD | -0.47 | 0.08 |
| Stochastic Oscillator | 1.15 | 78.06 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2025.